Medical News

RSS

Researchers identify genetic mutation associated with reckless drunken behavior

University of Helsinki researchers have identified a genetic mutation which renders carriers susceptible to particularly impulsive and reckless behaviour when drunk. More than one hundred thousand Finns carry this mutation.

17 Nov 2015

VHI publishes new report on efficiency and productivity of hospitals, nursing homes

Virginia Health Information has published its 2015 report on the efficiency and productivity of hospitals and nursing homes. The report boils down mountains of data into key indicators of efficiency and productivity. The report was designed to meet the needs of large employers and purchasers of care.

17 Nov 2015

Horn Lake Family Practice named EHE-certified preventive care center

EHE International, a nationally recognized leader in preventive medicine and annual physical exams, announced today that Horn Lake Family Practice in Horn Lake, MS, has been named an EHE-certified preventive care center. Through Dr. Achin Sharma, EHE members in the Memphis region now have greater access to its preventive care program to help them proactively maintain their health.

17 Nov 2015

New Directions Behavioral Health launches Student Assistance Program to support campus counseling services

Rates of anxiety and depression among college students in the U.S. have risen rapidly in the past decade. Students are showing up at college counseling centers only to discover they often must wait weeks and even months to see a mental health expert. In response, New Directions Behavioral Health® (New Directions) announced the launch of its Student Assistance Program to support and expand existing campus counseling services and resources.

17 Nov 2015

HITLAB selects five finalists for HITLAB World Cup

HITLAB has selected five finalists for its HITLAB World Cup, an international competition that promotes original solutions to pressing healthcare challenges. The best and brightest in healthcare innovation, the finalists, will present their ideas at the HITLAB Innovators SummitSM on December 4, 2015, at Columbia University's Alfred Lerner Hall.

17 Nov 2015

Vitamin E shows same efficacy in diabetic and nondiabetic patients

There have been numerous studies on the safety and efficacy of using vitamin E to treat nondiabetic patients with nonalcoholic steatohepatitis (NASH), but researchers at the annual meeting of the American Association for the Study of Liver Diseases presented results of vitamin E in diabetic and nondiabetic patients.

17 Nov 2015

BioSpa 8 automated incubator announced by BioTek

BioTek Instruments released the BioSpa™ 8 Automated Incubator, a unique platform that links microplate washers and dispensers with readers and imaging systems for unattended workflow automation.

17 Nov 2015

Viking submits IND application to FDA to conduct VK2809 Phase 2 study in patients with LDL-C and fatty liver disease

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration to conduct a Phase 2 study of VK2809 in patients with hypercholesterolemia and fatty liver disease.

17 Nov 2015

First patient enrolled in Phase 2 clinical trial of Immune's bertilimumab in Ulcerative Colitis

Immune Pharmaceuticals Inc. announced today that the first patient has been enrolled into the Phase 2 clinical trial evaluating the safety and efficacy of its first in class fully human monoclonal antibody, bertilimumab in Ulcerative Colitis (UC).

17 Nov 2015

Mylan announces U.S. launch of generic AXERT tablets

Mylan N.V. today announced the U.S. launch of Almotriptan Tablets USP, 6.25 mg and 12.5 mg, the generic version of Janssen Pharmaceutical's AXERT.

17 Nov 2015

Researchers use large-scale computer modeling to show effects of confinement on cell macromolecules

Using large-scale computer modeling, researchers have shown the effects of confinement on macromolecules inside cells -- and taken the first steps toward simulating a living cell, a capability that could allow them to ask 'what-if' questions impossible to ask in real organisms.

17 Nov 2015

RNA-based drugs provide many advantages over CRISPR/Cas9 gene editing system

In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired -- permanently editing a gene, but only temporarily activating CRISPR-Cas9.

17 Nov 2015

Structural differences in key brain region linked to hallucinations in people diagnosed with schizophrenia

People diagnosed with schizophrenia who are prone to hallucinations are likely to have structural differences in a key region of the brain compared to both healthy individuals and people diagnosed with schizophrenia who do not hallucinate, according to research published today.

17 Nov 2015

Study may lead to development of highly accurate screening test for early-stage ovarian cancer

Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.

17 Nov 2015

China Pharma's revenue decreases 19.5% to $4.8 million in Q3 2015

China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the financial results for the quarter ended September 30, 2015.

17 Nov 2015

DaVincian Healthcare forms strategic partnerships to improve patient outcomes in rural and remote areas

DaVincian Healthcare, a leading innovator in the mobile health and wellness industry, today announced strategic partnerships with social welfare and global technology companies to help remotely connect healthcare providers with patients in need, particularly those in rural and remote areas of the world.

17 Nov 2015

AstraZeneca announces FDA approval of TAGRISSO (AZD9291) for treatment of lung cancer patients

AstraZeneca today announced that the US Food and Drug Administration has approved TAGRISSO (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.

17 Nov 2015

Researchers find ranibizumab drug as effective alternative to laser therapy for treating diabetic retinopathy

In a randomized clinical trial of more than 300 participants, researchers from Johns Hopkins and elsewhere have found that ranibizumab — a drug most commonly used to treat retinal swelling in people with diabetes — is an effective alternative to laser therapy for treating the most severe, potentially blinding form of diabetic retinal disease. Results of the government-sponsored study also show that the drug therapy carries fewer side effects than the currently used laser treatment.

17 Nov 2015

Positive data from AbbVie's HCV clinical development program presented at The Liver Meeting of AASLD

AbbVie, a global biopharmaceutical company, today announced data from the SURVEYOR studies of its investigational HCV regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, an NS5A inhibitor, that show high rates of sustained virologic response at 12 weeks post-treatment (SVR 12) in non-cirrhotic patients with chronic hepatitis C virus (HCV) infection.

17 Nov 2015

People confused about antibiotic resistance, shows WHO survey

As the World Health Organization ramps up its fight against antibiotic resistance, a new multi-country survey shows people are confused about this major threat to public health and do not understand how to prevent it from growing.

17 Nov 2015

Medical News

Researchers identify genetic mutation associated with reckless drunken behavior

VHI publishes new report on efficiency and productivity of hospitals, nursing homes

Horn Lake Family Practice named EHE-certified preventive care center

New Directions Behavioral Health launches Student Assistance Program to support campus counseling services

HITLAB selects five finalists for HITLAB World Cup

Vitamin E shows same efficacy in diabetic and nondiabetic patients

BioSpa 8 automated incubator announced by BioTek

Viking submits IND application to FDA to conduct VK2809 Phase 2 study in patients with LDL-C and fatty liver disease

First patient enrolled in Phase 2 clinical trial of Immune's bertilimumab in Ulcerative Colitis

Mylan announces U.S. launch of generic AXERT tablets

Researchers use large-scale computer modeling to show effects of confinement on cell macromolecules

RNA-based drugs provide many advantages over CRISPR/Cas9 gene editing system

Structural differences in key brain region linked to hallucinations in people diagnosed with schizophrenia

Study may lead to development of highly accurate screening test for early-stage ovarian cancer

China Pharma's revenue decreases 19.5% to $4.8 million in Q3 2015

DaVincian Healthcare forms strategic partnerships to improve patient outcomes in rural and remote areas

AstraZeneca announces FDA approval of TAGRISSO (AZD9291) for treatment of lung cancer patients

Researchers find ranibizumab drug as effective alternative to laser therapy for treating diabetic retinopathy

Positive data from AbbVie's HCV clinical development program presented at The Liver Meeting of AASLD

People confused about antibiotic resistance, shows WHO survey

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News